Spruce Biosciences has taken…
Spruce Biosciences has taken another step toward filing for FDA [...]
Roche has taken its obesity…
Roche has taken its obesity strategy into uncharted territory via [...]
Werewolf Therapeutics’ hunt for…
Werewolf Therapeutics’ hunt for strategic alternatives has ended. Ambros Therapeutics [...]
Boehringer Ingelheim has suspended…
Boehringer Ingelheim has suspended a phase 1 trial of an [...]
Joshua Pinto, Ph.D., has been…
Joshua Pinto, Ph.D., has been appointed chief executive officer of [...]
Eli Lilly has turned to one of its…
Eli Lilly has turned to one of its Gateway Labs [...]
As the dust settles on phase 3…
As the dust settles on phase 3 data that added [...]
Pheast Therapeutics may have…
Pheast Therapeutics may have learned the hard way about the [...]
TScan has told Fierce that its…
TScan has told Fierce that its pipeline strategy remains unchanged [...]
After three months without a…
After three months without a permanent leader in place, President [...]